Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02191501 · ClinicalTrials.gov registry record · NA

Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity

A NA study, sponsored by Northwell Health.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT02191501: Clinical Trial NA study, sponsored by Northwell Health.

NCT02191501 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02191501, a NA study, was terminated before completion, sponsored by Northwell Health.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate the efficacy and safety of endoscopic suturing of the gastric pylorus to delay gastric emptying and treat obesity.

Primary Outcome

The primary endpoint of this study is percent weight loss at 1, 3 and 6 months (using the weight taken at the baseline visit as the baseline weight). Percent weight lost will be calculated as follows: \[(Baseline Weight - Final 6 month Weight)/Baseline Weight\] x 100%.

Interventions

  • PROCEDURE Pyloric restriction

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-05-07
Est. Completion 2017-11-09
Phase NA
Northwell Health

370 total trials

Why NCT02191501 stopped before completion

NCT02191501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Pyloric restriction is the first listed.

NCT02191501 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02191501 about?

NCT02191501 is a clinical study titled "Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity". The purpose of this study is to demonstrate the efficacy and safety of endoscopic suturing of the gastric pylorus to delay gastric emptying and treat obesity.

What is the current status of trial NCT02191501?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2013-05-07. Estimated completion is 2017-11-09.

What interventions are being tested in trial NCT02191501?

The interventions under investigation include: Pyloric restriction (PROCEDURE).

Who is sponsoring clinical trial NCT02191501?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02191501's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02191501, the US trial registry maintained by the National Library of Medicine. NCT02191501 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.